MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Anteile 2011-2026 | QTNT
Anteile Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 91.6 M | 71.6 M | 54.9 M | 40.8 M | 28.1 M | 19.6 M | 14.8 M | 18.4 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 91.6 M | 14.8 M | 42.5 M |
Anteile Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.25 M | 3.71 M | 3.44 M | 2.57 M | 2.55 M | 2.54 M | 2.54 M | 101 M | 101 M | 83.9 M | 83.9 M | 80.5 M | 73.8 M | 73.8 M | 66.3 M | 66.1 M | 56.6 M | 56.6 M | 52.1 M | 45.6 M | 43.4 M | 37.7 M | 36.8 M | 29.6 M | 29.5 M | 27.7 M | 26.8 M | 25.4 M | 20.4 M | 18.3 M | 17.2 M | 17 M | 15.1 M | 14.4 M | 12.8 M | 342 K | 829 K | 144 K | 237 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 101 M | 144 K | 34.3 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 29.7 | 3.74 % | $ 20 B |  Niderland |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 121.87 | 3.06 % | $ 37 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 20.67 | -8.13 % | $ 222 M |  China |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 21.42 | -4.46 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.56 | 6.85 % | $ 2.08 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 25.05 | 2.0 % | $ 696 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 183.88 | 3.92 % | $ 9.11 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 194.75 | 0.5 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.0 | -9.09 % | $ 8.85 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 5.08 | 1.6 % | $ 470 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.35 | 2.33 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.51 | 2.92 % | $ 2.06 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 520.6 | 0.96 % | $ 15 B | USA |
 |
Illumina
ILMN
|
159 M | $ 134.5 | 1.34 % | $ 21.4 B | USA |
 |
Precipio
PRPO
|
1.61 M | $ 28.3 | -2.41 % | $ 45.4 M | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.26 | 0.81 % | $ 492 M | USA |
 |
Guardant Health
GH
|
125 M | $ 90.36 | 5.44 % | $ 11.3 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 6.77 | - | $ 282 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.91 | 2.83 % | $ 94.4 K | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.78 | 0.4 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.18 | -0.91 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 119.68 | 3.55 % | $ 9.87 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 270.68 | 1.62 % | $ 22.5 B | USA |
 |
Neuronetics
STIM
|
66 M | $ 1.42 | 1.43 % | $ 93.7 M | USA |
 |
Celcuity
CELC
|
46.8 M | $ 122.46 | -2.23 % | $ 5.73 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 83.82 | -0.12 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 526.6 | 2.05 % | $ 199 B | USA |
 |
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.75 | 6.62 % | $ 61.9 M | Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 195.02 | 1.86 % | $ 21.6 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 6.4 | 23.79 % | $ 5.04 M | USA |